Status of and strategies for improving adherence to COPD treatment

References

• Bogart M, Stanford RH, Laliberte F, Germain G, Wu JW, Duh MS. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019;14:343–352. doi:10.2147/COPD.S18465330863037
   PubMed Web of Science ®Google Scholar
• Watts RW, McLennan G, Bassham I, el-Saadi O. Do patients with asthma fill their prescriptions? A primary compliance study. Aust Fam Physician. 1997;26(Suppl 1):S4–S6.9009028
   PubMedGoogle Scholar
• Sabaté E, editor. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
   Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47. doi:10.1111/j.1524-4733.2007.00213.x18237359
   PubMed Web of Science ®Google Scholar
• Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–1288.16868217
   PubMed Web of Science ®Google Scholar
• Rand CS. Patient adherence with COPD therapy. Eur Respir Rev. 2005;14(96):97–101.
   Google Scholar
• Van Ganse E, Price D. Respiratory medication adherence: toward a common language and a shared vision. J Allergy Clin Immunol Pract. 2016;4(5):799–801.27587313
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.22486599
   PubMed Web of Science ®Google Scholar
• Vrijens B, Dima AL, Van Ganse E, et al. What we mean when we talk about adherence in respiratory medicine. J Allergy Clin Immunol Pract. 2016;4(5):802–812.27587314
   PubMed Web of Science ®Google Scholar
• Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314. doi:10.4065/mcp.2010.057521389250
   PubMed Web of Science ®Google Scholar
• Gossec L, Tubach F, Dougados M, Ravaud P. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci. 2007;334(4):248–254. doi:10.1097/MAJ.0b013e318068dde818030180
   PubMed Web of Science ®Google Scholar
• Imamura Y, Kawayama T, Kinoshita T, et al. Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease. Allergol Int. 2017;66(3):482–484. doi:10.1016/j.alit.2016.10.00827887878
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra05010016079372
   PubMed Web of Science ®Google Scholar
• Hameed MA, Dasgupta I. Medication adherence and treatment-resistant hypertension: a review. Drugs Context. 2019;8:212560. doi:10.7573/dic.21256030774692
   PubMedGoogle Scholar
• Donohue JF, Singh D, Munzu C, Kilbride S, Church A. Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: results from two randomised controlled trials. Respir Med. 2016;112:65–74. doi:10.1016/j.rmed.2016.01.00126797016
   PubMed Web of Science ®Google Scholar
• Feldman GJ, Sousa AR, Lipson DA, et al. Comparative efficacy of once-daily umeclidinium/vilanterol and tiotropium/olodaterol therapy in symptomatic chronic obstructive pulmonary disease: a randomized study. Adv Ther. 2017;34(11):2518–2533. doi:10.1007/s12325-017-0626-429094315
   PubMed Web of Science ®Google Scholar
• Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11:149. doi:10.1186/1471-2288-11-14922050830
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.3945130
   PubMed Web of Science ®Google Scholar
• Barnestein-Fonseca P, Leiva-Fernandez J, Vidal-Espana F, Garcia-Ruiz A, Prados-Torres D, Leiva-Fernandez F. Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med. 2011;11:6. doi:10.1186/1471-2466-11-621261951
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354.18453793
   PubMed Web of Science ®Google Scholar
• Montes de Oca M, Menezes A, Wehrmeister FC, et al. Adherence to inhaled therapies of COPD patients from seven Latin American countries: the LASSYC study. PLoS One. 2017;12(11):e0186777. doi:10.1371/journal.pone.018677729140978
   PubMed Web of Science ®Google Scholar
• Duarte-de-Araujo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: understanding patients’ adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767–2773. doi:10.2147/COPD.S16098230233167
   PubMed Web of Science ®Google Scholar
• Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res. 2008;64(1):41–46. doi:10.1016/j.jpsychores.2007.05.00418157998
   PubMed Web of Science ®Google Scholar
• Hahn SR, Park J, Skinner EP, et al. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 2008;24(7):2127–2138. doi:10.1185/0300799080217476918554431
   PubMed Web of Science ®Google Scholar
• Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother. 2009;43(10):1621–1630. doi:10.1345/aph.1M17419776298
   PubMed Web of Science ®Google Scholar
• Toyama T, Kawayama T, Kinoshita T, et al. Differences in adherence barriers to inhaled medicines between japanese patients with chronic obstructive pulmonary disease and asthma evaluated using the “Adherence starts with knowledge 20” (ASK-20) questionnaire. Intern Med. 2019;58(2):175–185. doi:10.2169/internalmedicine.0488-1730210101
   PubMed Web of Science ®Google Scholar
• Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health. 2009;12(1):118–123. doi:10.1111/j.1524-4733.2008.00400.x19911444
   PubMed Web of Science ®Google Scholar
• Chabowski M, Luczak J, Dudek K, Jankowska-Polanska B. Sleep disorders and adherence to inhalation therapy in patients with chronic obstructive pulmonary disease. Adv Exp Med Biol. 2019.
   Web of Science ®Google Scholar
• Tommelein E, Mehuys E, Van Tongelen I, Brusselle G, Boussery K. Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD. Ann Pharmacother. 2014;48(5):589–595. doi:10.1177/106002801452298224523393
   PubMed Web of Science ®Google Scholar
• George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128(5):3198–3204. doi:10.1378/chest.128.5.319816304262
   PubMed Web of Science ®Google Scholar
• Plaza V, Lopez-Vina A, Cosio BG, en representacion del Comite Cientifico del Proyecto TAI. Test of Adherence to Inhalers. Arch Bronconeumol. 2017;53(7):360–361. doi:10.1016/j.arbres.2016.08.00627756657
   PubMed Web of Science ®Google Scholar
• Plaza V, Fernandez-Rodriguez C, Melero C, et al. Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/jamp.2015.121226230150
   PubMed Web of Science ®Google Scholar
• Plaza V, Lopez-Vina A, Entrenas LM, et al. Differences in adherence and non-adherence behaviour patterns to inhaler devices between COPD and asthma patients. COPD. 2016;13(5):547–554. doi:10.3109/15412555.2015.111844926788620
   PubMedGoogle Scholar
• Yin J, Yuan J, Hu Y, Wei X. Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150511. doi:10.1371/journal.pone.015051126930287
   PubMed Web of Science ®Google Scholar
• D’Arcy S, MacHale E, Seheult J, et al. A method to assess adherence in inhaler use through analysis of acoustic recordings of inhaler events. PLoS One. 2014;9(6):e98701. doi:10.1371/journal.pone.009870124905012
   PubMed Web of Science ®Google Scholar
• Sulaiman I, Cushen B, Greene G, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(10):1333–1343. doi:10.1164/rccm.201604-0733OC27409253
   PubMed Web of Science ®Google Scholar
• Carpenter DM, Roberts CA, Sage AJ, George J, Horne R. A review of electronic devices to assess inhaler technique. Curr Allergy Asthma Rep. 2017;17(3):17. doi:10.1007/s11882-017-0684-328290015
   PubMed Web of Science ®Google Scholar
• Sentellas S, Ramos I, Alberti J, et al. Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites. Eur J Pharm Sci. 2010;39(5):283–290. doi:10.1016/j.ejps.2010.01.00420093184
   PubMed Web of Science ®Google Scholar
• Sechaud R, Renard D, Zhang-Auberson L, Motte Sde L, Drollmann A, Kaiser G. Pharmacokinetics of multiple inhaled NVA237 doses in patients with chronic obstructive pulmonary disease (COPD). Int J Clin Pharmacol Ther. 2012;50(2):118–128.22257577
   PubMed Web of Science ®Google Scholar
• Clearie KL, Williamson PA, Vaidyanathan S, Du Bois J, Nell H, Lipworth BJ. Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. Br J Clin Pharmacol. 2010;69(6):637–644. doi:10.1111/j.1365-2125.2010.03655.x20565455
   PubMed Web of Science ®Google Scholar
• Hassall D, Brealey N, Wright W, et al. Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD. Pulm Pharmacol Ther. 2018;51:59–64. doi:10.1016/j.pupt.2018.07.00129981458
   PubMed Web of Science ®Google Scholar
• Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J, Group VANS. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003;6(5):566–573. doi:10.1046/j.1524-4733.2003.65269.x14627063
   PubMed Web of Science ®Google Scholar
• Zhang Z, Peluso MJ, Gross CP, Viscoli CM, Kernan WN. Adherence reporting in randomized controlled trials. Clin Trials. 2014;11(2):195–204. doi:10.1177/174077451351256524357665
   PubMed Web of Science ®Google Scholar
• Agh T, Inotai A, Meszaros A. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011;82(4):328–334. doi:10.1159/00032445321454953
   PubMed Web of Science ®Google Scholar
• Ismaila A, Corriveau D, Vaillancourt J, et al. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients. Curr Med Res Opin. 2014;30(7):1427–1436. doi:10.1185/03007995.2014.90882824666181
   PubMed Web of Science ®Google Scholar
• Huetsch JC, Uman JE, Udris EM, Au DH. Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med. 2012;27(11):1506–1512. doi:10.1007/s11606-012-2130-522782274
   PubMed Web of Science ®Google Scholar
• Arfe A, Nicotra F, Cerveri I, et al. Incidence, predictors, and clinical implications of discontinuing therapy with inhaled long-acting bronchodilators among patients with chronic obstructive pulmonary disease. COPD. 2016;13(5):540–546. doi:10.3109/15412555.2016.114187726934569
   PubMedGoogle Scholar
• Mueller S, Wilke T, Bechtel B, Punekar YS, Mitzner K, Virchow JC. Non-persistence and non-adherence to long-acting COPD medication therapy: a retrospective cohort study based on a large German claims dataset. Respir Med. 2017;122:1–11. doi:10.1016/j.rmed.2016.11.00827993284
   PubMed Web of Science ®Google Scholar
• Humenberger M, Horner A, Labek A, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163.30340565
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen TS, Marott JL, Nordestgaard BG, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30(1):51–59.25245885
   PubMed Web of Science ®Google Scholar
• Wurst KE, St Laurent S, Mullerova H, Davis KJ. Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2014;9:1021–1031.25285002
   PubMed Web of Science ®Google Scholar
• Penning-van Beest F, van Herk-Sukel M, Gale R, Lammers JW, Herings R. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis. Respir Med. 2011;105(2):259–265.20705441
   PubMed Web of Science ®Google Scholar
• Kardas P, Lewek P, Strzondala M. Adherence to treatment in asthma and COPD patients in their doctors’ assessment. Pneumonol Alergol Pol. 2015;83(6):436–444.26559796
   PubMedGoogle Scholar
• Laforest L, Denis F, Van Ganse E, et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J. 2010;19(2):148–154.20094689
   PubMedGoogle Scholar
• Laforest L, Licaj I, Devouassoux G, Hartwig S, Marvalin S, Van Ganse E. Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease. Chron Respir Dis. 2013;10(1):11–18.23149384
   PubMed Web of Science ®Google Scholar
• Donner CF, Amaducci S, Bacci E, et al. Inhalation therapy in the next decade: determinants of adherence to treatment in asthma and COPD. Monaldi Arch Chest Dis. 2018;88(1):886.29557582
   PubMed Web of Science ®Google Scholar
• Nishi SPE, Maslonka M, Zhang W, Kuo YF, Sharma G. Pattern and adherence to maintenance medication use in medicare beneficiaries with chronic obstructive pulmonary disease: 2008-2013. Chronic Obstr Pulm Dis. 2018;5(1):16–26.29629401
   PubMed Web of Science ®Google Scholar
• Melzer AC, Ghassemieh BJ, Gillespie SE, et al. Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respir Med. 2017;123:124–130.28137488
   PubMed Web of Science ®Google Scholar
• Amin AN, Ganapathy V, Roughley A, Small M. Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease. Patient Prefer Adherence. 2017;11:1205–1212.28744110
   PubMed Web of Science ®Google Scholar
• Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108(2):358–365.24209768
   PubMed Web of Science ®Google Scholar
• Darba J, Ramirez G, Sicras A, Francoli P, Torvinen S, Sanchez-de la Rosa R. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients. Int J Chron Obstruct Pulmon Dis. 2015;10:2335–2345.26604733
   PubMed Web of Science ®Google Scholar
• Koehorst-Ter Huurne K, Movig K, van der Valk P, van der Palen J, Brusse-Keizer M. The influence of type of inhalation device on adherence of COPD patients to inhaled medication. Expert Opin Drug Deliv. 2016;13(4):469–475.26666841
   PubMed Web of Science ®Google Scholar
• Chouaid C, Germain N, De Pouvourville G, et al. Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Curr Med Res Opin. 2019;35(5):785–792.30681007
   PubMed Web of Science ®Google Scholar
• Braido F, Chrystyn H, Baiardini I, et al. “Trying, but failing” - the role of inhaler technique and mode of delivery in respiratory medication adherence. J Allergy Clin Immunol Pract. 2016;4(5):823–832.27587316
   PubMed Web of Science ®Google Scholar
• Yu AP, Guerin A, Ponce de Leon D, et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ. 2011;14(4):486–496.21679019
   PubMedGoogle Scholar
• Wisniewski D, Porzezinska M, Gruchala-Niedoszytko M, Niedoszytko M, Slominski JM, Jassem E. Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol. 2014;82(2):96–104.24615193
   PubMedGoogle Scholar
• Krauskopf K, Federman AD, Kale MS, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD. 2015;12(2):151–164.24960306
   PubMedGoogle Scholar
• Shrestha R, Pant A, Shakya Shrestha S, Shrestha B, Gurung RB, Karmacharya BM. A cross-sectional study of medication adherence pattern and factors affecting the adherence in chronic obstructive pulmonary disease. Kathmandu Univ Med J (KUMJ). 2015;13(49):64–70.26620752
   PubMedGoogle Scholar
• Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012;9(3):251–258.22497533
   PubMedGoogle Scholar
• Di Martino M, Ventura M, Cappai G, et al. Adherence to long-acting bronchodilators after discharge for COPD: how much of the geographic variation is attributable to the hospital of discharge and how much to the primary care providers? COPD. 2017;14(1):86–94.27419396
   PubMedGoogle Scholar
• Tottenborg SS, Lange P, Johnsen SP, Nielsen H, Ingebrigtsen TS, Thomsen RW. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respir Med. 2016;119:160–167.27692139
   PubMed Web of Science ®Google Scholar
• Trivedi RB, Bryson CL, Udris E, Au DH. The influence of informal caregivers on adherence in COPD patients. Ann Behav Med. 2012;44(1):66–72.22422104
   PubMed Web of Science ®Google Scholar
• Toy EL, Beaulieu NU, McHale JM, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011;105(3):435–441.20880687
   PubMed Web of Science ®Google Scholar
• Izquierdo JL, Paredero JM, Piedra R. Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:289–293.26929614
   PubMed Web of Science ®Google Scholar
• Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012;68(10):1365–1373.22476392
   PubMed Web of Science ®Google Scholar
• Turan O, Turan PA, Mirici A. Parameters affecting inhalation therapy adherence in elderly patients with chronic obstructive lung disease and asthma. Geriatr Gerontol Int. 2017;17(6):999–1005.27426234
   PubMed Web of Science ®Google Scholar
• Adesanoye DT, Willey CJ. Does cardiovascular comorbidity influence the prescribing of bronchodilators in chronic obstructive pulmonary disease? Ann Pharmacother. 2017;51(10):855–861.28573879
   PubMed Web of Science ®Google Scholar
• Dhamane AD, Schwab P, Hopson S, et al. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:115–122.28053521
   PubMed Web of Science ®Google Scholar
• Kale MS, Federman AD, Krauskopf K, et al. The association of health literacy with illness and medication beliefs among patients with chronic obstructive pulmonary disease. PLoS One. 2015;10(4):e0123937.25915420
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943.19703830
   PubMed Web of Science ®Google Scholar
• Belleudi V, Di Martino M, Cascini S, et al. The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach. Pharmacoepidemiol Drug Saf. 2016;25(11):1295–1304.27396695
   PubMed Web of Science ®Google Scholar
• van Boven JF, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res. 2014;15:66.24929799
   PubMed Web of Science ®Google Scholar
• van Boven JF, Chavannes NH, van der Molen T, Rutten-van Molken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108(1):103–113.24070566
   PubMed Web of Science ®Google Scholar
• Kim JA, Lim MK, Kim K, Park J, Rhee CK. Adherence to inhaled medications and its effect on healthcare utilization and costs among high-grade chronic obstructive pulmonary disease patients. Clin Drug Investig. 2018;38(4):333–340.
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Bourbeau J. Self-management strategies in chronic obstructive pulmonary disease: a first step toward personalized medicine. Curr Opin Pulm Med. 2018;24(2):191–198.29278544
   PubMed Web of Science ®Google Scholar
• Takemura M, Mitsui K, Itotani R, et al. Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:97–104.21407822
   PubMed Web of Science ®Google Scholar
• Melani AS, Paleari D. Maintaining control of chronic obstructive airway disease: adherence to inhaled therapy and risks and benefits of switching devices. COPD. 2016;13(2):241–250.26407924
   PubMedGoogle Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: gold executive summary. Arch Bronconeumol. 2017;53(3):128–149.28274597
   PubMed Web of Science ®Google Scholar
• Braido F, Baiardini I, Sumberesi M, Blasi F, Canonica GW. Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res. 2013;14:94.24053694
   PubMed Web of Science ®Google Scholar
• Leiva-Fernandez J, Leiva-Fernandez F, Garcia-Ruiz A, Prados-Torres D, Barnestein-Fonseca P. Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial. BMC Pulm Med. 2014;14:70.24762026
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–795.22964778
   PubMed Web of Science ®Google Scholar
• Braido F, Lavorini F, Blasi F, Baiardini I, Canonica GW. Switching treatments in COPD: implications for costs and treatment adherence. Int J Chron Obstruct Pulmon Dis. 2015;10:2601–2608.26664108
   PubMed Web of Science ®Google Scholar
• Wright D, Twigg M, Thornley T. Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health intervention. Int J Pharm Pract. 2015;23(1):83–85.25371146
   PubMedGoogle Scholar
• Castillo D, Burgos F, Guayta R, et al. Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis. Respir Med. 2015;109(4):475–482.25754101
   PubMed Web of Science ®Google Scholar
• Xin C, Xia Z, Jiang C, Lin M, Li G. The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study. Patient Prefer Adherence. 2016;10:1197–1203.27468229
   PubMed Web of Science ®Google Scholar
• Arabyat RM, Raisch DW, Bakhireva L. Influenza vaccination for patients with chronic obstructive pulmonary disease: implications for pharmacists. Res Social Adm Pharm. 2018;14(2):162–169.28533080
   PubMed Web of Science ®Google Scholar
• Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320(23):2461–2473.30561486
   PubMed Web of Science ®Google Scholar
• Normansell R, Kew KM, Stovold E. Interventions to improve adherence to inhaled steroids for asthma. Cochrane Database Syst Rev. 2017;4:Cd012226.28417456
   PubMed Web of Science ®Google Scholar
• Dennison L, Morrison L, Conway G, Yardley L. Opportunities and challenges for smartphone applications in supporting health behavior change: qualitative study. J Med Internet Res. 2013;15(4):e86. doi:10.2196/jmir.258323598614
   PubMed Web of Science ®Google Scholar
• Blakey JD, Bender BG, Dima AL, Weinman J, Safioti G, Costello RW. Digital technologies and adherence in respiratory diseases: the road ahead. Eur Respir J. 2018;52(5). doi:10.1183/13993003.01675-2018
   Web of Science ®Google Scholar